MLC1 Overexpression Inhibits Tumor Progression through PI3K/AKT Signal Pathway in Prostate Cancer

Researchers validated modulator of volume-regulated anion channel current 1 (MLC1)’s anti-tumor effects and uncover potential mechanisms. MLC1 expression was significantly reduced in prostate cancer samples compared with the adjacent normal tissues.